Where it's made
| Factory | Where | Role | Last FDA inspection |
|---|---|---|---|
| Sanofi-Aventis Deutschland GmbH | Frankfurt am Main, Germany | Makes it, makes the active ingredient, tests it, packages it and labels it | Problems found, fixed voluntarilyMar 25, 2022 · 10 inspections, 1 with FDA action |
Recalls
- Apr 11, 2023 · Class II · Sanofi-Aventis U.S. LLC
Lack of Assurance of Sterility: Malformed crimped collar seal
Lots: Lot # 3F497B, EXP 12-31-2025 - Jul 5, 2018 · Class II · Sanofi-Aventis U.S. LLC
Temperature Abuse: Product samples of Admelog may not have been shipped at proper temperature.
Lots: Lot #: 7F021B, Exp 6/30/20
Class I recalls are the most serious; Class III the least. A recall covers specific lots, listed on each recall.
Product details
- Generic drug
- Insulin Lispro: every company that makes it
- Form
- injection, solution, intravenous; subcutaneous
- Strength
- 100 U per 1 mL
- Approval
- BLA BLA209196
- On the market since
- Dec 11, 2017
- Package NDCs
0024-5924-10- Official label
- DailyMed (National Library of Medicine), updated Jun 4, 2025
Got it by mail or from a pharmacy you don't know? Look the pharmacy up on Who Filled My Rx?